{"id":"tp-48432","type":"article-newspaper","title":"Madrigal Plans MASH Cirrhosis Trial With More Than 2,000 Patients for 2027","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/48432","datePublished":"2026-11-04T11:36:29.000Z","dateModified":"2026-11-04T11:36:29.000Z","language":"en","abstract":"The planned Phase 3 MAESTRO-CSPH study is targeted to start in the first half of 2027, pending regulatory discussions. Madrigal expects results in the early 2030s.","section":"Business","references":[]}